ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Ischemia"

  • 2015 American Transplant Congress

    The Liver X Receptor Alpha (LXRα) Knockout Protect Liver Against Ischemia-Reperfusin Injury in Mice

    T. Lu,1 D. Li,1 J. Zhang,1 M. Zhang,1 X. Cui,1 H. Dai,1 X. Liu,2 Q. Xia.1

    1Liver Surgery and Liver Transplantation Center, Renji Hospital, Shanghai, China; 2Cardiovascular, Shanghai First People's Hospital, Shanghai, China.

    Background: Liver X Receptor Alpha (LXRα) is a transcription factor crucial for cholesterol, fatty acid, and glucose homeostasis. We hypothesize that LXRαKO may promote hepatocellular…
  • 2015 American Transplant Congress

    Kidney and Liver CIT Variations Across OPOs and Their Implications: US Experience Between 2003 and 2011

    J. Melancon, N. Koizumi, C. Callender, D. DasGupta, T. Smith.

    Surgery, George Washington University, Washington, DC; Public Policy, George Mason University, Arlington, VA; Surgery, Howard University, Washington, DC; Health Sciences, University of Indianapolis, Indianapolis, IN; School of Engineering, University of Pennsylvania, Philadelphia, PA.

    Introduction: Significant variations in kidney and liver transplant outcomes across OPOs have been reported, but their causes remain largely unknown. This study investigated variations in…
  • 2015 American Transplant Congress

    A 10 Min “No-Touch” Time – Is It Enough in DCD? A DCD Animal Study

    M. Sereinigg,1 V. Stadlbauer,2 T. Seifert-Held,3 F. Iberer,1 P. Stiegler.1

    1Department for Transplant Surgery, Medical University Graz, Graz, Austria; 2Department for Gastroenterology and Hepatology, Medical University Graz, Graz, Austria; 3Department for Neurology, Medical University Graz, Graz, Austria.

    Introduction: DCD is under investigation due to the lack of human donor organs. Required times of cardiac arrest vary between 75 seconds and 27 min…
  • 2015 American Transplant Congress

    Activation of FXR Protects Against Liver Ischemia and Reperfusion Injury (IRI) in Mice Via the PI 3-Kinase/Akt (PI3K/Akt) Pathway

    J. Zhang,1 X. Liu,2 D. Li,1 H. Dai,1 J. Zhang,1 T. Lu,1 Q. Xia.1

    1Liver Transplantation Center, Renji Hospital, Shanghai, China; 2Cardiovascular, Shanghai First People/s Hospital, Shanghai, China.

    Background: FXR is a ligand-dependent transcription factor belonging to the nuclear hormone receptor superfamily, which plays important roles in lipid metabolism, glucose homeostasis, inflammatory responses…
  • 2015 American Transplant Congress

    Engagement of the Vasopressin Receptor On Hepatocytes Protects Liver from Ischemia-Reperfusion Injury Via the WNT-β-Catenin-SGK1-FOXO Pathway

    X. Liu,1 T. Billiar,2 R. Tao.1

    1Department of Hepatobiliary-Pancreatic Surgery, Zhejiang Provincial Peoples' Hospital, Hangzhou, Zhejiang Province, China; 2Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

    The synthetic vasopressin analogue, terlipressin, has been extensively used in the management of certain complications associated with end-stage liver diseases (ESLDs), however concerns have been…
  • 2015 American Transplant Congress

    Mesenchymal Stem Cells Prevent Cold Ischemia-Reperfusion Injury in Lung Transplants

    H. Wang,1,2 W. Tian,1 Y. Liu,3 X. Dai,1 G. Li,3 T. Liu,1,2 Z. Zhang,1,2 C. Du.4

    1Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China; 2Tianjin General Surgery Institute, Tianjin, China; 3Department of Biology, Tianjin Medical University, Tianjin, China; 4Department of Urologic Sciences, The University of British Columbia, Vancouver, BC, Canada.

    Background: Cold ischemia-reperfusion injury (IRI) is a major cause of graft failure in lung transplantation. Despite therapeutic benefits of mesenchymal stem cells (MSCs) in attenuating…
  • 2015 American Transplant Congress

    Macrophage Specific β-Catenin Controls ROCK/PTEN Function and Regulates Innate Immunity in Liver Inflammation

    S. Yue,1 X. Zhou,2 M. Zhou,1 Y. Zhai,1 R. Busuttil,1 Q. Ying,2 J. Kupiec-Weglinski,1 B. Ke.1

    1Dumont-UCLA Transplant Center, Dept. of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA; 2Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Dept. of Stem Cell Biology & Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

    Background: It has been shown that β-catenin is an important regulator of cell development, regeneration, and carcinogenesis. Our previous studies demonstrated the key role of…
  • 2015 American Transplant Congress

    Galectin-9 Protects Mouse Liver Transplants Against Ischemia-Reperfusion Injury

    H. Ji, Y. Liu, Y. Zhang, X. Shen, F. Gao, R. Busuttil, J. Kupiec-Weglinski.

    Dept of Surgery, Dumont-UCLA Liver Transplant Center, Los Angeles, CA.

    Background:Although Galecin 9 (Gal-9) negatively regulates Th1-type alloimmunity by binding to T-cell Immunoglobulin Mucin-3 (TIM-3) on activated Th1 cells, its role in liver ischemia-reperfusion injury…
  • 2015 American Transplant Congress

    Delivery of Heme Oxygenase-1-Cell Penetrating Peptide (HO-1-CPP) Into Hepatocytes, Kupffer and Islet Cells in In Vitro and Ex Vivo Models of Cold Ischemia

    A. Venkatachalam,1 C. Wood,1 Q. Hu,1 I. Alwayn.2

    1Surgery, Dalhousie University, Halifax, NS, Canada; 2Surgery, Pathology, Microbiology & Immunology, Surgical Lead Multi Organ Transplant Program, QEII Health Sciences Center, Dalhousie University, Halifax, NS, Canada.

    In an attempt to increase the number of donor organs available to transplantation extended criteria donor (ECD) organs are more frequently considered. Unfortunately, ECD organs…
  • 2015 American Transplant Congress

    Cellular Mechanism of Enhanced Alloimmunity by Ischemia Reperfusion Injury

    Z. Solhjou, M. Uehara, S. Ohori, M. McGrath, J. Azzi, S. Tullius, R. Abdi.

    Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

    Ischemia reperfusion injury of transplanted organs represents a key pathogenic inflammatory process, which increases their allogenicity; subsequently augmenting the rate of acute and chronic rejection.…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences